Risperdal Breast Growth Side Effects in Young Boys

There are not many things that sicken me, since I contemplate myself of being of firm abdominal fortitude, armed with progressive medical knowledge and a intelligence of right and wrong, inspired at an early age by my settler parents.

Risperdal Gynecomastia AttorneyBut, let’s throw that guileless sentiment out of the window. I of late read the excellent series of Risperdal articles by Steve Brill in the Huffington Post, concerning the Risperdal tragedy and the possible illegal actions by key Johnson and Johnson (J&J) and its lesser Janssen directors in the marketing and sales of their blockbuster anti-psychotic pill, Risperdal. These are must-reads for everybody. To get more information about Risperdal Breast Growth Side effects you can visit at risperdalgynecomastialawsuitcenter.

Risperdal Causes Abnormal Breast Growth in Males

The latest medical investigation found that side belongings of Risperdal use among boys and young men rises the risk of irregular breast growth, called gynecomastia.

In the August issue of the Journal of Child and Adolescent Psychopharmacology, University of British Columbia researchers found that use of Risperdal surges the risk of gynecomastia breast growth in teens and young men by a factor of four, or by 400%.

What is Risperdal?

Risperdal (risperidone) is a blockbuster antipsychotic medication, mass marketed mainly to children for handling of schizophrenia, bipolar complaint and touchiness associated with autism.

Risperdal Undeniably Causes Abnormal Breast Growth

Risperdal has severe side effects, the worst of which reasons an increase in the blood levels of hormone prolactin. Prolactin is a protein hormone that causes and continues lactation (milk production) in women after they give birth.

For boys and young men using Risperdal, preceding medical research has linked Risperdal to the development of distended breasts.

In this latest study involving more than 400,000 male’s ages 15-25, using the IMS Life Link database, investigators found 1,556 cases of gynecomastia and compared them with 15,560 corresponding controls.

The study found, Risperdal users were 3.91 times more likely to develop gynecomastia than boys and young men who did not take the drug. When researchers looked just at those under the age of 18, the risk increased to more than a factor of five.The researchers concluded, “Our study showed a strong association between risperidone use and gynecomastia in young adult males.”